When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“When is thrombophilia testing appropriate and how can the evidence help guide clinical care?
In this expert panel from World Thrombosis Day, presented in partnership with Sysmex Europe, leading voices in thrombosis explore evidence based approaches to thrombophilia screening and management.
Featuring Lana Castellucci, and Cihan Ay, with moderator Andreas Rechner, the discussion covers hereditary thrombophilia, Factor V Leiden, antiphospholipid syndrome (APS), appropriate testing, clinical management and future directions in thrombosis care.
Watch the full 45 minute discussion and deepen your understanding of this evolving area of thrombosis care.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters